These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22522403)

  • 1. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
    Fogari R; Zoppi A; Maffioli P; Mugellini A; Preti P; Perrone T; Derosa G
    Clin Cardiol; 2012 Jun; 35(6):359-64. PubMed ID: 22522403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.
    Fogari R; Mugellini A; Zoppi A; Preti P; Destro M; Lazzari P; Derosa G
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):34-43. PubMed ID: 21335482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
    Galzerano D; Di Michele S; Paolisso G; Tuccillo B; Lama D; Carbotta S; Cittadini A; Tedesco MA; Gaudio C
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):496-503. PubMed ID: 22546623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
    Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
    Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
    Pan G; Zhou X; Zhao J
    Cardiovasc Ther; 2014 Aug; 32(4):184-8. PubMed ID: 24645740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
    Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
    Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
    Kario K; Hoshide S; Uchiyama K; Yoshida T; Okazaki O; Noshiro T; Aoki H; Mizuno H; Matsumoto Y
    J Clin Hypertens (Greenwich); 2016 Oct; 18(10):1036-1044. PubMed ID: 26989846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
    Ma H; Jiang H; Feng J; Gan Y
    Cardiovasc Ther; 2021; 2021():6628469. PubMed ID: 34104205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan and prevention of atrial fibrillation recurrence in hypertensive patients.
    Fogari R; Mugellini A; Destro M; Corradi L; Zoppi A; Fogari E; Rinaldi A
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):46-50. PubMed ID: 16424784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
    Liu W; Wang W; Song SW; Gu XF; Ma XJ; Su FY; Zhang H; Liu AJ; Su DF
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):308-16. PubMed ID: 21266915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of telmisartan in the treatment of hypertension.
    White WB
    J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):20-5. PubMed ID: 12147925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
    Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
    Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients).
    Ley L; Schumacher H
    Curr Med Res Opin; 2013 Jan; 29(1):41-53. PubMed ID: 23157465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
    Terashima M; Kaneda H; Nasu K; Matsuo H; Habara M; Ito T; Tanaka N; Rathore S; Kinoshita Y; Kimura M; Ehara M; Suzuki Y; Suzuki T
    JACC Cardiovasc Interv; 2012 Feb; 5(2):182-90. PubMed ID: 22361603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Clin Cardiol; 2011 Apr; 34(4):261-5. PubMed ID: 21432858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of telmisartan on paroxysmal atrial fibrillation in hypertensive patients.
    Li J; Chen H; Zhou Q; Hu L; Ma L; Han H; Li W; Du R; Tian L
    Pak J Pharm Sci; 2017 Sep; 30(5):1651-1655. PubMed ID: 29084686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
    Neldam S; Edwards C;
    Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
    Yamagishi S; Takenaka K; Inoue H
    Med Hypotheses; 2006; 66(1):118-20. PubMed ID: 16154710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.